Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33085
Title: Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule.
Austin Authors: Waldron, Jamie L;Rose, Morgan T ;Vogrin, Sara;Krantz, Matthew S;Bolotte, Ryan;Phillips, Elizabeth J;Trubiano, Jason A
Affiliation: Infectious Diseases
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.;Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.;Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.;Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
Issue Date: 1-Jun-2023
Date: 2023
Publication information: JAMA Network Open 2023-06-01; 6(6)
Abstract: This cohort study describes the adaptation of a widely used penicillin allergy clinical decision tool for evaluation of trimethoprim-sulfamethoxazole allergy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/33085
DOI: 10.1001/jamanetworkopen.2023.16776
ORCID: 
Journal: JAMA Network Open
Start page: e2316776
PubMed URL: 37273210
ISSN: 2574-3805
Type: Journal Article
Subjects: Anti-Bacterial Agents/adverse effects
Drug Hypersensitivity/diagnosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

40
checked on Nov 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.